NCT02241564View on ClinicalTrials.gov

Malignancies in Transplanted Patients

CompletedOBSERVATIONAL
Enrollment

95

Participants

Timeline

Start Date

November 30, 2007

Primary Completion Date

June 30, 2017

Study Completion Date

June 30, 2017

Conditions
Neoplasms
Interventions
OTHER

Referral to a multidisciplinary expert panel at the Uppsala University Hospital after tumor detection

DRUG

Switch from calcineurin inhibitor to an mTOR inhibitor

Trial Locations (1)

SE-75185

Department of Surgery, Section of Transplantation Surgery, Uppsala University Hospital, Uppsala

All Listed Sponsors
lead

Uppsala University

OTHER

NCT02241564 - Malignancies in Transplanted Patients | Biotech Hunter | Biotech Hunter